The Journal of Allergy and Clinical Immunology: In Practice
Clinical CommunicationsThe safety of antibiotic skin testing in severe T-cell–mediated hypersensitivity of immunocompetent and immunocompromised hosts
References (15)
- et al.
A comparative analysis between antibiotic- and nonantibiotic-associated delayed cutaneous adverse drug reactions
J Allergy Clin Immunol Pract
(2016) - et al.
The combined utility of ex vivo IFN-gamma release enzyme-linked ImmunoSpot assay and in vivo skin testing in patients with antibiotic-associated severe cutaneous adverse reactions
J Allergy Clin Immunol Pract
(2018) - et al.
Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity
Curr Opin Infect Dis
(2016) - et al.
A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions
Br J Dermatol
(2013) Skin prick testing for the diagnosis of allergic disease. Australia: ASCIA
Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter
Ann Allergy Asthma Immunol
(2010)- et al.
Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions
Contact Dermatitis
(2001)
Cited by (23)
New Pathways to Navigate an Old Problem of Tuberculosis Therapy-Associated Adverse Drug Reactions
2021, Journal of Allergy and Clinical Immunology: In PracticeDirect Challenges for the Evaluation of Beta-Lactam Allergy: Evidence and Conditions for Not Performing Skin Testing
2021, Journal of Allergy and Clinical Immunology: In PracticeCitation Excerpt :Until recently, international guidelines have recommended that both pediatric and adult patients with benign reactions to BL should undergo ST and, if negative, a subsequent DPT. However, recent studies have demonstrated the safety of direct DPTs without preceding ST for both pediatric and adult patients who report a low-risk historical reaction to BLs.29,44-49,55,66-79 Most reactions that occur during DPTs are mild.29,40-43,64,83-85
Piperacillin-Tazobactam Hypersensitivity: A Large, Multicenter Analysis
2021, Journal of Allergy and Clinical Immunology: In PracticeCitation Excerpt :Previous case reports of PPZ-TZB hypersensitivity occurring on both occupational skin contact and inhalation4,5 prompt suggestions that PPZ-TZB may have a significant potential to elicit hypersensitivity in this way. Although skin testing in DRESS has historically been avoided, we found it was safe in the vast majority of patients, for both IHR and NIHR; none of the patients with NIH and only 1 patient with IH (with a history of occupational exposure) had a systemic reaction with ST. This confirms findings for antibiotic testing in general.34,35 Our results emphasize, once more, both the critical clinical value and the safety of ST and further strengthen the recommendation for skin testing before considering drug provocation.21,22
Delabeling Delayed Drug Hypersensitivity: How Far Can You Safely Go?
2020, Journal of Allergy and Clinical Immunology: In PracticeCitation Excerpt :In a recent consensus guideline, there was agreement amongst international experts that delayed IDT using sterile preparations of drugs can aid drug allergy assessment and that similar to PT should not be performed sooner than 4 to 6 weeks after an acute reaction.1 The use of IDT in SCAR has predominately been in the setting of hypersensitivity associated with anti-infective drugs that are commonly available as sterile preparations and for which the greatest delabeling need exists.79 Prior studies have indicated that IDT has increased sensitivity over PT and this appears particularly true for antibiotic-associated DRESS and MPE.80,81
Analysis of Skin-Resident Memory T Cells Following Drug Hypersensitivity Reactions
2020, Journal of Investigative DermatologySafety of cephalosporins in penicillin class severe delayed hypersensitivity reactions
2020, Journal of Allergy and Clinical Immunology: In Practice
This work was supported by the Austin Medical Research Foundation. J.A.T. is supported by a National Health and Medical Research Council (NHMRC) postgraduate scholarship (GNT 1139902) and a postgraduate scholarship from The National Centre for Infections in Cancer, National Health and Medical Research Council, Centre for Research Excellence (App 1116876). E.J.P. is supported in part by the National Institutes of Health (NIH) (award nos. 1P50GM115305-01 and 1R01AI103348-01), the NIH-funded Tennessee Center for AIDS Research (grant no. P30 AI110527), NIH grant number 1R13 AR071267-01, NHMRC, ACH2, and the Angela Anderson Foundation.
Conflicts of interest: The authors declare that they have no relevant conflicts of interest.